• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Justice...

Quote




Not in your world....but in the real world, yes, absolutely true and global sales are well over $100M

IF Osteohealth ever did $50M (which I doubt) it was including GEM sales and Heli line (which we know is small/cheap. The question is how long can they survive with a dramatic loss in revenue by losing Geistlich products (except Mucograft - which does about $1.5M) ? Nibec (mfg. of Equimatrix) is a public company and by their numbers, Osteohealth is not selling as much as people seem to think - sampling yes, but that clearly is not turning into repeat sales. I am sure they will next bring the crappy membrane...good luck

New reps=more investment and proven opportunity in the market and there are no guarantees....
 




Anonymous said:
Not a chance in the world. Nice try. If that were true, why are they hiring a bunch of new salespeople to find their old customers and giving them 6 figure guarantees???
Click to expand...

Xenografts and bio-oss were mentioned at the AO this last week in most of the surgical tracks regarding regeneration. Geistlich had their own corporate forum which was full.
Bio-Oss never went away (according to the Osteohealth reps it did)
Allografts are in for a tough time with lack of FDA approval, consistency etc.
Looks like Geistlich is kicking into 5th gear and going strong.
 




Anonymous said:
Equimatrix is all over the place. In my area every major university it using it whether it be OMS or Perio. Big names across the country are using it as their go-to xenograft now like Pikos, Cullum, Sclar, McAlister, Zadeh, the list goes on. It has not been on the market long enough to make claims that its better than BioOss, but the truth is that it's just as good.
Click to expand...

Can you tell me 1 name on this list that has paid for Equimatix? Every name listed I have spoken w told me they are getting it free as part of a "study."

Osteohealth is a joke, too bad bc it once was a great company with good management that understood the market and help set trends in the industry.
 




Anonymous said:
Not in your world....but in the real world, yes, absolutely true and global sales are well over $100M

IF Osteohealth ever did $50M (which I doubt) it was including GEM sales and Heli line (which we know is small/cheap. The question is how long can they survive with a dramatic loss in revenue by losing Geistlich products (except Mucograft - which does about $1.5M) ? Nibec (mfg. of Equimatrix) is a public company and by their numbers, Osteohealth is not selling as much as people seem to think - sampling yes, but that clearly is not turning into repeat sales. I am sure they will next bring the crappy membrane...good luck

New reps=more investment and proven opportunity in the market and there are no guarantees....[/QUOTE

It did do 50M without Gem and Heli products. Bio Gide slightly out sold Bio Oss. Not that it matters. Those days are long over. It tanked when the pharma guys took over management!
Click to expand...
 




Never did 50M w/o Gem...period (not opinion, fact)

Osteohealth history/performance is like a high school athlete who never turned pro....living in the past and told the lie so many times it feels real to them...they are legends in their own mind...and did not know how well they had it with Bio-Oss & Bio-Gide
 












































If interviewing with Osteohealth, be very careful. They are launching new products with little or no research and it is questionable whether GEM21 will be returning. Every rep at OH is looking to leave. At one point OH was a great spot to be, not anymore, not even for a pharma rep looking to advance.
 
















Top Bottom
Back
Quote